LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Use of tagatose to enhance key blood factors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Use of targeted oxidative therapeutic formulation in bone...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Use of targeted oxidative therapeutic formulation in...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Use of tasteless, hydrolyzed collagen and agent containing the s

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Use of taurolidine and/or taurultam for treatment of...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Use of taurolidine for treatment of leukemias

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Use of taurolidine to treat tumors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Use of taurolidine to treat tumors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Use of taxoid derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Use of taxol in the treatment of rheumatoid arthritis

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Use of tellurium containing compounds as nerve protecting...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Use of temperature to control the size of cationic liposome/plas

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Use of tempol for the treatment of Li-Fraumeni syndrome and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Use of tempol in the prevention of photoaging

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Use of tenidap to inhibit activation of collagenase and to inhib

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Use of tenidap to reduce total serum cholesterol, LDL cholestero

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...

Use of terbinafine for the therapeutic treatment of pneumocystos

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Use of terguride as a geriatric agent

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

Use of terpene compounds for reduced release of arachidonic acid